Evidence map›Paper›PMID 34650040›Full record

ArticleNature communications2021

Active droploids.

Jens Grauer, Falko Schmidt, Jesús Pineda, Benjamin Midtvedt, Hartmut Löwen, Giovanni Volpe, Benno Liebchen

Abstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jens Grauer *Institut für Theoretische Physik II: Weiche Materie, Heinrich-Heine-Universität Düsseldorf, D-40225, Düsseldorf, Germany.
Falko Schmidt *Department of Physics, University of Gothenburg, SE-41296, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-2041-4572
Jesús PinedaDepartment of Physics, University of Gothenburg, SE-41296, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-9197-3451
Benjamin MidtvedtDepartment of Physics, University of Gothenburg, SE-41296, Gothenburg, Sweden.
Hartmut LöwenInstitut für Theoretische Physik II: Weiche Materie, Heinrich-Heine-Universität Düsseldorf, D-40225, Düsseldorf, Germany.
Giovanni VolpeDepartment of Physics, University of Gothenburg, SE-41296, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-5057-1846
Benno LiebchenInstitut für Physik der kondensierten Materie, Technische Universität Darmstadt, D-64289, Darmstadt, Germany. benno.liebchen@pkm.tu-darmstadt.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Active matter comprises self-driven units, such as bacteria and synthetic microswimmers, that can spontaneously form complex patterns and assemble into functional microdevices. These processes are possible thanks to the out-of-equilibrium nature of active-matter systems, fueled by a one-way free-energy flow from the environment into the system. Here, we take the next step in the evolution of active matter by realizing a two-way coupling between active particles and their environment, where active particles act back on the environment giving rise to the formation of superstructures. In experiments and simulations we observe that, under light-illumination, colloidal particles and their near-critical environment create mutually-coupled co-evolving structures. These structures unify in the form of active superstructures featuring a droplet shape and a colloidal engine inducing self-propulsion. We call them active droploids-a portmanteau of droplet and colloids. Our results provide a pathway to create active superstructures through environmental feedback.

Identifiers

PMID34650040
PMCPMC8516867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.